Ixekizumab (Taltz) has been listed on the PBS from 1 March for the treatment of severe psoriatic arthritis. The interleukin-17A (IL-17A) inhibitor, will be available as an Authority Required listing for adult patients with severe psoriatic arthritis as monotherapy or in combination with cDMARDs in adult patients who have responded inadequately, or who are intolerant ...
Biologics listed on PBS for psoriatic arthritis and psoriasis
By Michael Woodhead
1 Mar 2019